High-dose Chemotherapy With Rituximab for Adults With Aggressive Large B-cell Lymphoma

Clinical trial NCT00965289 · COMPLETED

Trial details

NCT number: NCT00965289
Sponsor: Nantes University Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

B-Cell Lymphoma

Start date: 2002-04-01
Primary completion: 2003-05-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.